Results per Page:
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
HIV antibody trial results offer 'proof of concept'
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
HIV vaccine trials are complicated by the availability of PrEP
World AIDS Day 2020: Vaccine researchers still find ways to run trials amid growing use of HIV-prevention drugs
Tailoring vaccine trial recruitment to individual communities
From the HVTN, Vaccine and Infectious Disease Division
After 20 years, Wakefield retires from HIV Vaccine Trials Network
'He created the DNA of our organization'
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
Empowering ‘millions of women’ against HIV
AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
A new path to an AIDS vaccine?
A ‘landmark’ clinical trial called the AMP study launches on three continents to test HIV-blocking super antibodies